These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12172012)

  • 21. Influenza A virus molecular virology techniques.
    Zhou B; Wentworth DE
    Methods Mol Biol; 2012; 865():175-92. PubMed ID: 22528160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses.
    Deng YM; Iannello P; Caldwell N; Jelley L; Komadina N; Baas C; Kelso A; Barr IG
    J Clin Virol; 2013 Sep; 58(1):94-9. PubMed ID: 23692962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid-Based Reverse Genetics of Influenza A Virus.
    Perez DR; Seibert B; Ferreri L; Lee CW; Rajao D
    Methods Mol Biol; 2020; 2123():37-59. PubMed ID: 32170679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reassortants of influenza B viruses for use in vaccines: an evaluation.
    Goodeve AC; Jennings R; Potter CW
    Arch Virol; 1985; 83(3-4):169-79. PubMed ID: 3155942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs.
    Aslam S; Rajendran M; Kriti D; Kurland A; Johnson J; van Bakel H; Krammer F; García-Sastre A; Ayllon J
    NPJ Vaccines; 2023 Feb; 8(1):12. PubMed ID: 36765053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production.
    Fulvini AA; Ramanunninair M; Le J; Pokorny BA; Arroyo JM; Silverman J; Devis R; Bucher D
    PLoS One; 2011; 6(6):e20823. PubMed ID: 21695145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for influenza B virus lineage shifts and reassortants circulating in Thailand in 2014-2016.
    Tewawong N; Suntronwong N; Korkong S; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    Infect Genet Evol; 2017 Jan; 47():35-40. PubMed ID: 27845268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region.
    Cobbin JC; Ong C; Verity E; Gilbertson BP; Rockman SP; Brown LE
    J Virol; 2014 Aug; 88(16):8971-80. PubMed ID: 24872588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production.
    Neumann G; Fujii K; Kino Y; Kawaoka Y
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16825-9. PubMed ID: 16267134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational pattern of influenza B viruses adapted to high growth replication in embryonated eggs.
    Lugovtsev VY; Vodeiko GM; Levandowski RA
    Virus Res; 2005 May; 109(2):149-57. PubMed ID: 15763145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014.
    Oong XY; Ng KT; Lam TT; Pang YK; Chan KG; Hanafi NS; Kamarulzaman A; Tee KK
    PLoS One; 2015; 10(8):e0136254. PubMed ID: 26313754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.
    Keawcharoen J; Spronken MI; Vuong O; Bestebroer TM; Munster VJ; Osterhaus AD; Rimmelzwaan GF; Fouchier RA
    Vaccine; 2010 Aug; 28(36):5803-9. PubMed ID: 20600474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons.
    Shaw MW; Xu X; Li Y; Normand S; Ueki RT; Kunimoto GY; Hall H; Klimov A; Cox NJ; Subbarao K
    Virology; 2002 Nov; 303(1):1-8. PubMed ID: 12482653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Buffin S; Peubez I; Barrière F; Nicolaï MC; Tapia T; Dhir V; Forma E; Sève N; Legastelois I
    Vaccine; 2019 Oct; 37(46):6857-6867. PubMed ID: 31590935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
    Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
    Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An analysis on genetic characteristics of hemagglutinin and neuraminidase of type B influenza viruses in Guangzhou in 2006].
    Li XZ; Wu XW; Liu WS; Wang M; Chen YY; Wu YJ
    Bing Du Xue Bao; 2007 Sep; 23(5):356-9. PubMed ID: 17969851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
    PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV; Kodihalli S; Govorkova EA; Fanget B; Gerdil C; Webster RG
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.